We all know the ritual: your first sip of coffee in the morning feels like a gentle jolt, turning groggy thoughts into ...

HONG KONG, Nov. 16, 2025 /PRNewswire/ — Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed ...

GLP-1 receptor agonists, medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have become ...

Keon Coleman está nuevamente en problemas con los Bills. El receptor de segundo año fue descartado por razones disciplinarias ...

If you tend to experience seasickness when on a boat or during a cruise, this natural, easily accessible ingredient can keep ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

Experts today sounded an alarm over the death toll as millions more are in line to get the jabs to curb the nation's bulging ...

On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a ...

It has been almost two weeks since Kentucky Governor Andy Beshear banned Kratom extract 7-Hydroxymitraginyne, also known as 7 ...

Researchers have discovered a defect in how cells produce exosomes, a problem linked to a mutation found in patients with ...

San Francisco 49ers RB Christian McCaffrey muscled his way into the end zone from one yard out during the 49ers Week 11 ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...